IPHA   $1.8399999999999999  2.79% Market Closed After Close 1.82 -1.09%

Innate Pharma SA
Total Cash 91.80M
totalCashPerShare 1.134
EBITDA -35.96M
Total Debt 35.50M
quickRatio 2.763
currentRatio 2.919
Total Revenue 33.79M
debtToEquity 123.291
Revenue/Share 0.419
ROA -0.13758
ROE -0.78587997
grossProfits
freeCashflow 13.06M
operatingCashflow -18.06M
earningsGrowth
revenueGrowth -0.693
grossMargins -0.58769
ebitdaMargins -1.06425
operatingMargins -2.13147
profitMargins -1.00781
enterpriseValue 91.84M
forwardPE
floatShares 31.56M
sharesOutstanding 80.95M
sharesShort 58.78K
sharesShortPriorMonth 59.74K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.0
heldPercentInstitutions 0.00%
Short Ratio help_outline 6.28%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 0.356
Price To Book help_outline 5.79
earningsQuarterlyGrowth
netIncomeToCommon -34.05M
trailingEps -0.53%
forwardEps 0.45%
enterpriseToEbitda -2.55
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 10
lastUpdated Nov. 7, 2024, 4:59 a.m.